Physician profile
Shaun Ross
NPI 1740268333
$2,308.22
in general payments reported to CMS, 2019-2025
16 companies · $793 in 2025
The $793 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $339 · 2021: $228 · 2022: $140 · 2023: $14.77 · 2024: $404 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,172.63 | 2019-2025 | Ozempic, Rybelsus |
| Neurocrine Biosciences, INC. | $221.20 | 2025 | |
| Dexcom, INC. | $216.88 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $177.64 | 2019-2025 | Mounjaro, Zepbound |
| Insulet Corporation | $120.96 | 2024-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $78.39 | 2024-2025 | |
| Sanofi Pasteur INC. | $57.05 | 2024-2025 | |
| Abbott Laboratories | $55.54 | 2022-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $42.48 | 2025 | Farxiga |
| Antares Pharma, INC. | $36.96 | 2024 | Xyosted |
| Tandem Diabetes Care, INC. | $34.53 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $25.93 | 2025 | |
| Sunovion Pharmaceuticals INC. | $20.89 | 2019 | |
| Xeris Pharmaceuticals, INC. | $16.49 | 2025 | Gvoke Hypopen |
| Corcept Therapeutics | $15.88 | 2024 | Korlym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $14.77 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.